News

The U.S. Food and Drug Administration (FDA) cleared a smart watch artificial intelligence (AI) algorithm that tells wearers if they are suspected of having hypertension, which is expected to help notify about 1 million users over the next year. This a is a new feature of the newly launched Apple Watch Ultra 3, which the company unveiled Sept. 9. Apple gained FDA for its Cardiovascular Machine Learning-Based Notification Software Hypertension Notification Feature (HTNF) Sept. 11, 2025.

The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business. 

Thumbnail

Safety concerns with certain Boston Scientific leads has resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August. 

The tool analyzes routine hip and pelvis X-rays for signs of low bone mineral density.

Thumbnail

The Society of Interventional Radiology and American College of Radiology are thanking lawmakers for reintroducing the Resident Physician Shortage Reduction Act. 

wheelchair

Only 43% of women with disabilities receive American Society of Breast Surgeons-recommended mammography screening services, according to a new single-center study. 

Strategic Radiology

Colorado Springs Radiologists and its roughly 25 physicians are seeking to gain the benefits of scale without the challenges of consolidation. 

The Dexcom G7 Continuous Glucose Monitoring System

The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.

Thumbnail

The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."

Video interview with Pedro Martinez Clark, MD, an interventional cardiologist, who explains how he overcame some key health disparities in Miami to make sure minority patients in low-income neighborhoods could receive screenings and care for peripheral artery disease (PAD).

Pedro Martinez-Clark, MD, an interventional cardiologist and founder of Amavita Heart and Vascular Health, explains the health disparities he encounters that block the delivery of care in certain parts of Miami.

Imaging experts have said the move could reshape the financial landscape for hospitals offering Cardiac CT services.

money court scale of justice ruling legal settlement

“While the result was surprising and unsatisfying, we are nevertheless pleased that the panel rejected any recovery to UHC," the California-based practice said on Thursday. 

California State Capitol Sacramento

Annual private equity investment in healthcare reached $83B billion three years ago, but these transactions have faced little scrutiny to ensure they are in the public’s best interest, sponsors note. 

Around the web

The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business. 

Safety concerns with certain Boston Scientific leads has resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August.